A federal court has vacated a sweeping Education Department directive that led to the cancellation of more than $600 million in teacher training grants tied to diversity, equity, and inclusion programming. The
On 28 July 2026, the Federal Communications Commission’s Public Safety and Homeland Security Bureau released Public Notice DA 26-786, adding foreign-produced advanced robotic devices to the FCC’s Covered List. The Covered List
More
Acting Attorney General Todd Blanche posted a signed order to X late Sunday night formally rescinding the controversial Anti-Weaponization Fund he personally created earlier this year. The fund was established as part
More
Savvy investors are always searching for opportunities to get ahead of broader market movements before institutional money flows in. Identifying stocks before Wall Street analysts issue formal buy ratings can give retail
More
The FTSE 100 slipped into negative territory as a sharp sell-off in AstraZeneca (AZN) shares weighed heavily on the index’s overall performance. AstraZeneca is one of the most heavily weighted stocks on
More
Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to merge in an all-stock transaction creating a major central nervous system biopharmaceutical company. The combined entity will generate approximately $2.2 billion in annual revenue,
More
When a construction project goes wrong due to defective plans, slow RFI responses, or owner interference, the financial pain can be severe and very real. Costs pile up quickly, and contractors are
More
Private enforcers have issued over 2,600 notices of violation in California so far in 2026, with food, personal care, and apparel companies remaining the primary targets. The continued proliferation of Prop 65
More
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, marking the steepest single-day decline across the entire FTSE 100 index. The sell-off came after reports emerged that Britain’s largest drugmaker
More
The FTSE 250 index, which tracks mid-sized companies listed on the London Stock Exchange, has long been considered a barometer of the domestic UK economy. Unlike the FTSE 100, which is heavily
More
AstraZeneca’s shares fell sharply in early trading as investors expressed clear scepticism over a potential merger with US rival Bristol Myers Squibb. The UK drugmaker’s stock dropped six per cent to 11,866p
More